Retired
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I consider the $10.17 print on 6/9 as "out of range" noise and drew the line across the lower tops and think a break out occurred at ~$8.30
Broke the apex of the triangle to the upside.
And if backed up with a market cap valuation adjustment to the upside, this could get really interesting.
Of course this could be another top in the formation, but as you said, t's gotta give.
Gee wiz, maybe the WGT crowd got larger after that conference call and earnings report.
The people who follow my post know what they own, and how it's financed. So your comment does not represent my followers.
I will assume you are referring to all those who have and keep maintaining there will be no more dilution because WGT and revenue was and is coming in spades absolutely flooding Anavex with cash.
überraschen, “surprise, astonish, astound, overtake, and take aback.” is the plan indeed.
Soumit Roy has a 26% success rate. Well for context. That's not too bad when one covers a sector with 95% failure rate.
FUD, only simpletons don't understand the need for microcaps to have open lines of financing.
So true. In may ways being a good broker was reeling in your clients excitement and setting expectations accordingly and adjust their position size based on levels of confidence and client risk tolerance.
But, every biotech needs a WGT segment or none of them would get funded.
When investing is done correctly and "safely" within one risk tolerance and financial means, IMO, it's required to have some speculation in the portfolio.
FWIW, the data regarding the effect of a "drug holiday" was with PDD trial...not Rett.
https://www.anavex.com/post/anavex-2-73-blarcamesine-shows-clinical-benefit-in-long-term-48week-phase-2-extension-study-in-pdd
The period between the end of the double-blind phase to the start of the extension phase, where patients were not on ANAVEX®2-73 treatment, is known as a ‘drug holiday’. The drug holiday period of treatment separation provided an opportunity to compare the trajectory of clinical scores between no ANAVEX®2-73 treatment (drug holiday) and ANAVEX®2-73 treatment in the extension phase.
It would honestly take very little for $AVXL to shake off it's OTC origin story and that's delivering on milestones. Trust me I'm no Dr.M superfan but will give him a fair shake.
I'm of the opinion simply reporting out on Rett and a NDA timeline will bring in some buyers and firm up $AVXL's market cap. In addition a PD trial start by the MJFF supported "Shake it Up Foundation" could do the same. It's my "hope" this can break away the sympathetic trading pattern $AVXL has with the $XBI.
FUDsters post here every day
Maybe you are more naïve than I thought.
I'm agreeing, but I'm a d/ck? Every daily move up and down is not always due to come cabalish action as your narrative claims. That's my beef. Yes there are many market players and participants, but it's not all collusion.
That's all stuff I know already and hasn't changed much, I'm thinking a bit deeper into the mechanics and if use of the crossing session and it's guaranteed liquidity is an advantage "they" leverage when so few market centers process the volume?
It's a trend and pattern over time analysis, not simply a proportion question and this is different from the MOC order type available to some.
He's one of the people I hope see's it. But, his context of the system may be as old as mine. The trades and system gaming is based upon the recent changes to trading and systems.
It's probably nothing, but when I don't know how I ask. ;)
Now given the fact the payment for order flow has changed market functioning and reduced the number of market centers is there gaming of the system going on?
OMG I'm sounding more and more like "Sparky" every year. LOL!
If this makes any since to anyone, pls advise. ;)
The pattern I'm curious about is that for $AVXL there is consistently a bulk of the daily share volume traded (buy and a sell) conducted precisely at 16:00:00. Access to this negotiated price type of transaction is part of the feature set of trading as a NASDAQ listed stock.
Sometimes it's good, sometimes it's bad. Regardless it allows for a substantial amount of shares to be crossed at a guaranteed price. This type of liquidity has value to various market participants. My conspiracy hunch is because of way orders get processed in todays market, at a limited number of "market centers", there are inside departments and divisions that could take advantage of such value in combination with the payment for order flow model.
Am I crazy? Could there folks be the dastardly manipulative cabals? Sure why not. See it all on a Netflix special someday. LOL
The pattern I'm curious about is that for $AVXL there is consistently a bulk of the daily share volume traded (buy and a sell) conducted precisely at 16:00:00. Access to this negotiated price type of transaction is part of the feature set of trading as a NASDAQ listed stock.
Sometimes it's good, sometimes it's bad. Regardless it allows for a substantial amount of shares to be crossed at a guaranteed price. This type of liquidity has value to various market participants. My conspiracy hunch is because of way orders get processed in todays market, at a limited number of "market centers", there are inside departments and divisions that could take advantage of such value in combination with the payment for order flow model.
Am I crazy? Could there folks be the dastardly manipulative cabals? Sure why not. See it all on a Netflix special someday. LOL
$AVXL volume is poor and to me it trades "funky" via the crossing session.
Rumor has it, It's all the cabal's and their computers gaming the system. I've give that hunch a, you're probably right guess. LOL!
On a related tangent, I'm curious if there has been a good explanation of "why" there is so much crossing session volume for $AVXL?
True, but maybe I want attention too.
Now where's the fun in that?!?
I'm here for the entertainment. Next time try not replying. LOL
Very interesting that you asked that question, and that is precisely the reason why the rule was created in the first place.
Nobody is supposed to apply any importance or weight to those transactions conducted under that plan in the first place. And to eliminate any confusion that is the 375 share purchases from the very early days.
The most recent insider share purchase was specifically done via rule 144. Specifics of the transactions do matter.
I use insider ownership and insider trades as a tertiary indicator.
My comment then really wasn't for you then was it. It was for anyone who reads the thread.
Learning is a choice....
I just explained the how, you'll have to ask the executive, Dr. Missing the reasons for his decision on amounts and timing.
I believe these topics have been covered before.
Yep, the support zone has been poked more than enough. Damn MM cabalish bastards!
In the simplest of terms when an executive of a publicly traded company wishes to purchase or sell shares of his stock, but he may have "inside knowledge" , thus these plans are set up for executives to buy or sell set amounts of stock overset periods of time. From a risk management standpoint, and the executives point of view, this allows them to escape scrutiny of market timing the transactions.
And regarding your question as to why an executive may choose not to execute stock options early? There can be a multitude of reasons it's not my job to explain it all for free how would I get fee revenue as an advisor?!?
Also, let us not forget the recent incentive stock option exercise was due to an expiration, not a free will transaction.
Think whatever you want, but don't be a simpleton on how the process works.
For people who can only spin the negative, the CEO is dammed if they do, damned if the don't it seems.
Why, because 375 shares per transaction was the number derived by the total amount to be invested divided by a set number of days, over a set period to follow rule 10b5-1
The "375" share transactions had no special meaning.
So why did Missling buy that weird series of 375 $AVXL shares some years back that send speculation flying?
LOL, I'll take that as confirmation of your simpleton view of venture capital.
Standard simpleton view of venture capital you have there.
Do you not have equity based venture capital in your country?
Agreeable #'s and I also take into consideration the $AVXL moves in sympathy with the $XBI which is testing it's own 200 day SMA.
Feeling better?
Just go back to the weekly chart, take deep breaths.
When are we gonna replace them rat skulls with some humans?
Time to start shaking, We're looking at you Shake it Up Foundation.
And poof... just like that the technicals improve.
Long Term Support....is NOT broken!
In order to see that level, you need to use the WEEKLY CHARTS...which clearly shows a level down to appx $7.43, yes we broke short term support, but not going back to May 2022 when the important low was put in! We've had multiple strikes down to this area and, so far, it has held up...I think it was challenged 4 to 5 times now. My opinion, so I can definitely be proven wrong...the link should illustrate:
https://tinyurl.com/3xzm9pts
As I mentioned yesterday, there is an ongoing effort to break psychology, so I might have my head handed to me! Won't be the first time; I did see the market's engulfing bearish reversal, so time is money or less money.
100% agreement.
For $$AVXL to run up we will need to see a non typical Anavex clear and unfumbled positive EXCELLENCE readout.
None of the development stage equities that ran up to the $1B to $3B market caps were sustainable, but market participants will drive a price to whatever the market will bear. And on a bearish note, none of the macro economic conditions that allowed for such market moves are present for such an event to happen today. Company specific material events can of course rally the market cap.
LOL Definitely not therapy!!! Instead, a good broker or FA.
Everyone with that investment illness must get some therapy to make money, especially in biotech.
LOL, he's a long time ignore. Time to buy when he shows up. LOL!
Looks like you were denied confirmation.
Material industry ($RETA) news is involved which makes it all the more interesting.